Skip to main content
Clinical Trials/PACTR202006915898923
PACTR202006915898923
Not yet recruiting
未知

Efficacy, safety and quality of life of oxybutynin versus aluminum chloride hexahydrate in treating primary palmar hyperhidrosis

Mansoura university faculty of medicine0 sites80 target enrollmentMay 8, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Skin and Connective Tissue Diseases
Sponsor
Mansoura university faculty of medicine
Enrollment
80
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 8, 2020
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • The study include patients with primary palmar hyperhidrosis aged nine years or more with Hyperhidrosis Disease Severity Scale (HDSS) of at least 2 and agree to keep on follow\-up.

Exclusion Criteria

  • Pregnant and lactating women, hypersensitive to any of the active ingredients or have a history of hypersensitivity, known closed angle glaucoma or known prostatic disorders, intestinal obstruction, toxic megacolon, intestinal atony, severe ulcerative colitis, and myasthenia.

Outcomes

Primary Outcomes

Not specified

Similar Trials